3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
4
Sleep Initiation and Maintenance Disorders
3
Multiple Myeloma
1
Lymphoma
1
Depression
1
Color Vision Defects
1
Cognitive Dysfunction
1
Cancer Pain
1
Bone Neoplasms
1
Anxiety Disorders
1
Interventions
Oxycodone
5
Morphine
5
nabiximols
4
Naloxone
2
Fentanyl
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
naloxegol
1
incobotulinumtoxinA
1
Water
1
Transcranial Direct Current Stimulation
1
Tapentadol
1
Sodium Bicarbonate
1
Methadone
1
Lidocaine
1
Lenalidomide
1
Ketamine
1
Inosine Monophosphate
1
Hydromorphone
1
Glucose
1
Donepezil
1
Cognitive Behavioral Therapy
1
Buprenorphine
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Cancer Pain
×
Cognitive Behavioral Therapy
×
Clear all
NCT05774197
2025-11-04
STAMP+CBT
University of Oklahoma
Phase NA
Completed
52 enrolled
7 charts